Skip to main content
Check out our Award Winning BabyMatters by Gerber Medical Hub interactive infographic, Starting Solid Foods!
  • Gerber Good Start GentlePro Powder Infant Formula Container Front
  • Gerber Good Start GentlePro Powder Infant Formula Container Side
  • Gerber Good Start GentlePro Powder Infant Formula Container Back
  • Gerber Good Start GentlePro Powder Infant Formula Container Side
zoom_in

Gerber® Good Start® GentlePro Powder

Our closest formula to breastmilk.  Advanced complete nutrition with easy to digest proteins, 2’-FL HMO** & Probiotic B.lactis.^

High Quality 100% Whey Protein, Partially Hydrolyzed

  • Small proteins that are easy to digest
  • Promotes softer stools*
  • Clinically shown to deliver a gastric emptying time similar to breastmilk at 30 minutes
  • May help reduce the risk of developing atopic dermatitis†

Probiotic B. lactis^

  • Supports digestive health
  • Clinically shown to promote a balanced microbiota
  • Clinically shown to support the developing immune system by increasing IgA, a key antibody

Prebiotic 2’-FL HMO** (Human Milk Oligosaccharide)

  • A prebiotic like those found at significant levels in breastmilk
  • Clinically shown to support digestive health and the developing immune system

DHA

  • Expert-recommended DHA to support brain & eye development

 

* Compared to intact (non-hydrolyzed) cow’s milk protein formula
† For healthy infants who are exclusively breastfed and who have a family history of allergy, feeding a 100% whey protein partially hydrolyzed infant formula, like Gerber® Good Start® GentlePro, from birth up to 4 months of age instead of a formula made with intact cow’s milk proteins may reduce the risk of developing atopic dermatitis throughout the first year of life. Not for treatment.
^ Probiotic found in Gerber® Good Start® Gentle and Gentle Pro powder formula only
** Human milk oligosaccharides (HMOs) are a group of prebiotics found in human milk, and 2’-FL is the most abundant found in breastmilk. The 2’-FL HMO in Gerber® Good Start® is structurally identical to that in breastmilk, not from human milk.

Ingredients

Whey Protein Concentrate (from Milk, Enzymatically Hydrolyzed, Reduced in Minerals), Vegetable Oils (Palm Olein, Soy, Coconut, High Oleic Safflower or High Oleic Sunflower), Lactose, Corn Maltodextrin, and Less than 2% of: Potassium Hydroxide, Calcium Chloride, Potassium Phosphate, Calcium Phosphate, Choline Bitartrate, 2'-0-Fucosyllactose*, Citric Acid, M, Alpina Oil**, Schizochytrium Oil***, Sodium Ascorbate, Magnesium Chloride, Sodium Citrate, Soy Lecithin, Taurine Nucleotides (Cytidine 5'-Monophosphate, Disodium Uridine 5’-Monophosphate, Adenosine 5'-Monophosphate, Disodium Guanosine 5'-Monophosphate), Inositol, Ferrous Sulfate, Alpha-Tocopheryl Acetate, Mixed Tocopherols, Ascorbyl Palmitate, Zinc Sulfate, Niacinamide, Calcium Pantothenate, B. Lactis Cultures, L-Carnitine, Copper Sulfate, Riboflavin, Thiamine Mononitrate, Vitamin A Acetate Pyridoxine Hydrochloride Manganese Sulfate Potassium Iodide Folic Acid, Phylloquinone, Biotin, Sodium Selenate, Vitamin D3, Vitamin B12.

Contains: Milk and Soy

Nestle Infant Nutrition,
Arlington, VA 22209 USA

* A Source of Prebiotic

* A Source of Arachidonic Acid (ARA)

** A Source of Docosahexaenoic Acid (DHA)

Note: Information is subject to change. Please read the formula label for the most up-to-date nutritional information and preparation instructions.

Nutrition Information

  Per 100 calories Per 100 mL Per Liter (prepared) Per 100 grams of powder Per mL
Nutrients
Energy, kcal 100 68 676 512 0.68
Volume, mL 148 100 1000 - 1.00
Water, g 133 90 900 - 0.90
Protein, g 2.2 1.5 14.9 11.26 0.01
% Calories 9% 9% 9% 9% 9%
Protein source 100% whey partially hydrolyzed
Fat, g 5.1 3.4 34.5 26.1 0.03
% Calories 46% 46% 46% 46% 46%
Fat source 38% palm olein oil, 35% soy oil, 19% coconut oil, 6% high oleic safflower or sunflower oil, 2% single cell oil
Linoleic Acid, mg 900 609 6087 4608 6.09
Linolenic Acid, mg 85 57 575 435 0.57
DHA, % total fat 0.32 0.32 0.32 2 0.32
ARA, % total fat 0.32 0.32 0.32 2 0.32
Carbohydrate, g 11.6 7.8 78.5 59 0.08
% Calories 45% 45% 45% 45% 45%
Carbohydrate source 70% lactose, 30% maltodextrin
Prebiotic, g/L 0.25 g/L, 2'-FL HMO
Vitamins
Vitamin A, IU 300 203 2029 1536 2.03
Vitamin D, IU 60 41 406 307 0.41
Vitamin E, IU 2 1.4 14 10 0.01
Vitamin K, mcg 8 5.4 54 41 0.05
Thiamine (Vitamin B1), mcg 100 68 676 512 0.68
Riboflavin (Vitamin B2), mcg 140 95 947 717 0.95
Vitamin B6, mcg 75 51 507 384 0.51
Vitamin B12, mcg 0.33 0.22 2.2 1.7 0.002
Niacin, mcg 1050 710 7102 5376 7.10
Folic Acid, mcg 15 10 101 77 0.10
Pantothenic Acid, mcg 450 304 3044 2304 3.04
Biotin, mcg 4.4 3 30 23 0.03
Vitamin C, mg 10 6.8 68 51 0.07
Choline, mg 24 16 162 123 0.16
Inositol, mg 6 4.1 41 31 0.04
Minerals
Calcium, mg 67 45 453 343.04 0.45
Phosphorus, mg 38 26 257 194.56 0.26
Magnesium, mg 7 4.7 47 35.84 0.05
Iron, mg 1.5 1 10 7.68 0.01
Zinc, mg 0.8 0.54 5.4 4.10 0.01
Manganese, mcg 15 10 101 76.80 0.10
Copper, mcg 80 54 541 409.60 0.54
Iodine, mcg 12 8.1 81 61.44 0.08
Selenium, mcg 3 2 20 15.36 0.02
Sodium, mg 27 18 183 138.24 0.18
Potassium, mg 108 73 730 552.96 0.73
Chloride, mg 65 44 440 332.80 0.44
Other
Probiotic, CFU/g powder^ 1 x 106, B. lactis
Added Nucleotides, mg 5 3.4 34 25.60 0.03
PRSL, mOsm per 100 kcal 19.6 - - -  
PRSL, mOsm per 100 mL - 13.3 - - 0.13
PRSL, mOsm per liter - - 133 -  
Osmolality, mOsm/kg water 255 255 255 - 2.55

‡ Nutrient values and ingredient information current as of October 2, 2022. Values are
subject to change. Please refer to product label for current information.

¶ Human Milk oligosaccharide. Not from Human Milk ^

CFU = Colony Forming Units

Amino Acid Values Gerber® Good Start® Formulas for Term Infants
GERBER® GOOD START® GentlePro Formula
Amino Acid mg/100 kcal mg/100 g mg/100ml mg/ml
Histidine 47 242 32 0.32
Isoleucine 158 810 107 1.07
Leucine 266 1360 180 1.80
Lysine 215 1102 145 1.45
Methionine 50 258 34 0.34
Phenylalanine 87 443 59 0.59
Threonine 170 869 115 1.15
Tryptophan 45 230 30 0.30
Valine 144 737 97 0.97
Alanine 116 580 78 0.78
Arginine 56 280 38 0.38
Aspartic Acid 260 1303 176 1.76
Cystine 71 362 48 0.48
Glutamic Acid 386 1937 261 2.61
Glycine 44 223 30 0.30
Proline 139 700 94 0.94
Serine 116 583 78 0.78
Tyrosine 75 386 51 0.51
Fatty Acid Profiles Gerber® Good Start® Formulas for Term Infants
GERBER® GOOD START® GentlePro Formula
Fatty Acid mg/100 kcal mg/100 g
Butyric Acid (C-4:0) 1 8
Caproic Acid (C-6:0) 7 38
Caprylic Acid (C-8:0) 69 355
Capric Acid (C-10:0) 54 276
Lauric Acid (C-12:0) 416 3131
Myristic Acid (C-14:0) 186 954
Palmitic Acid (C-16:0) 1016 5203
Stearic Acid (C-18:0) 192 984
Other Saturated Acids 31 159
Total Saturated Acids 1974 10108
Palmitoleic Acid (C-16:1) 6 33
Oleic Acid (C-18:1) 1444 7391
Other Monounsaturated Acids 13 66
Total Monounsaturated Acids 1463 7489
Linoleic (n-6) Acid (C-18:2) 1092 5590
Linolenic (n-3) Acids (C-18:3) 124 636
ARA (C-20:4) 17 87
EPA (C-20:5) 0 0
DHA (C-22:6) 15 77
Other Polyunsaturated Acids 7 34
Total Polyunsaturated Acids 1255 6424

Resources

Videos & Presentations

Abstracts

Bode L. Human Milk Oligosaccharides: Next-Generation Functions and Questions. Nestle Nutr Inst Workshop Ser. 2019;90:191-201. doi: 10.1159/000490306. Epub 2019 Mar 13.

Bridgman SL, Konya T, Azad MB, Sears MR, Becker AB, Turvey SE, Mandhane PJ, Subbarao P; CHILD Study Investigators, Scott JA, Field CJ, Kozyrskyj AL. Infant gut immunity: a preliminary study of IgA associations with breastfeeding. J Dev Orig Health Dis. 2016 Feb;7(1):68-72. doi: 10.1017/S2040174415007862.

Chan YH, Shek LP, Aw M, Quak SH, Lee BW. Use of hypoallergenic formula in the prevention of atopic disease among Asian children. J Paediatr Child Health. 2002;38:84-88.

De Seta L, Siani P, Cirillo G, Di Gruttola M, Cimaduomo L, Coletta S. The prevention of allergic diseases with a hypoallergenic formula: a follow-up at 24 months. The preliminary results [in Italian]. Pediatr Med Chir. 1994;16:251–254.

D’Agata A, Betta P, Sciacca P, et al. Role of dietary prevention in newborns at risk for atopy. Results of a follow-up study [in Italian]. Pediatr Med Chir. 1996;18:469-472.

Donovan SM, Comstock SS. Human Milk Oligosaccharides Influence Neonatal Mucosal and Systemic Immunity. Ann Nutr Metab. 2016;69 Suppl 2:42-51. doi: 10.1159/000452818. Epub 2017 Jan 20.

Exl BM, Deland U, Secretin MC, Preysch U, Wall M, Shmerling DM. Improved general health status in an unselected infant population following an allergen-reduced dietary intervention programme: the ZUFF-STUDY-PROGRAMME. Part II: infant growth and health status to age 6 months. ZUg-FraunFeld. Eur J Nutr. 2000;39:145-156.

Fioramonti J, Theodorou V, Bueno L. Probiotics: what are they? What are their effects on gut physiology? Best Pract Res Clin Gastroenterol. 2003 Oct;17(5):711-24.

Fooks LJ, Gibson GR, Probiotics as modulators of the gut flora. Br J Nutr. 2002 Sep;88 Suppl 1:S39-49.

Greer FR, Sicherer SH, Burks AW; COMMITTEE ON NUTRITION; SECTION ON ALLERGY AND IMMUNOLOGY. The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing of Introduction of Allergenic Complementary Foods. Pediatrics. 2019 Apr;143(4). pii: e20190281. doi: 10.1542/peds.2019-0281. Epub 2019 Mar 18.

Hays T, Wood RA. A systematic review of the role of hydrolyzed infant formulas in allergy prevention. Arch Pediatr Adolesc Med. 2005;159:810-816.

Holscher HD, Faust KL, Czerkies LA, Litov R, Ziegler EE, Lessin H, Hatch T, Sun S, Tappenden KA. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial. JPEN J Parenter Enteral Nutr. 2012 Jan;36(1 Suppl):95S-105S. doi: 10.1177/0148607111430087.

Huda MN, Ahmad SM, Alam MJ, Khanam A, Kalanetra KM, Taft DH, Raqib R, Underwood MA, Mills DA, Stephensen CB. Bifidobacterium Abundance in Early Infancy and Vaccine Response at 2 Years of Age. Pediatrics. 2019 Feb;143(2). pii: e20181489. doi: 10.1542/peds.2018-1489.

Isolauri E, Rautava S, Salminen S, Collado MC. Early-Life Nutrition and Microbiome Development. Nestle Nutr Inst Workshop Ser. 2019;90:151-162. doi: 10.1159/000490302. Epub 2019 Mar 13.

Isolauri E. Summary of Normal Development of Gut Microbiota and Dysbiosis. Nestle Nutr Inst Workshop Ser. 2017;88:127-128. doi: 10.1159/000455221. Epub 2017 Mar 27.

Niers L1, Stasse-Wolthuis M, Rombouts FM, Rijkers GT. Nutritional support for the infant's immune system. Nutr Rev. 2007 Aug;65(8 Pt 1):347-60.

Rautava S. Microbial Composition of the Initial Colonization of Newborns. Nestle Nutr Inst Workshop Ser. 2017;88:11-21. doi: 10.1159/000455209. Epub 2017 Mar 27.

Rutayisire E, Huang K, Liu Y, Tao F. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants' life: a systematic review. BMC Gastroenterol. 2016 Jul 30;16(1):86. doi: 10.1186/s12876-016-0498-0.

Storm HM1, Shepard J, Czerkies LM, Kineman B, Cohen SS, Reichert H, Carvalho R. 2'-Fucosyllactose Is Well Tolerated in a 100% Whey, Partially Hydrolyzed Infant Formula With Bifidobacterium lactis: A Randomized Controlled Trial. J Pediatr.Glob Pediatr Health. 2019 Mar 15;6:2333794X19833995. doi: 10.1177/2333794X19833995. eCollection 2019.

Tetty Yuniaty, Fiva Kadi, Hadyana Sukandar, Mifta Novikasari, Pensri Kosuwon, Enea Rezzonico, Paiboon Piyabanditkul, Leilani Lestarina, Marco Turini Impact of Bifidobacterium lactis supplementation on fecal microbiota in infants delivered vaginally compared to Caesarean section Paediatrica Indonesiana. March 2013.

Vandenplas Y, Deneyer M, Sacre L, Loeb H. Preliminary data on a field study with a new hypoallergenic formula. Eur J Pediatr. 1988;148:274–227.

Vandenplas Y, Hauser B, Van den Borre C, et al. The long-term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. Eur J Pediatr. 1995;154:488-494.

Vandenplas Y, Berger B, Carnielli VP, Ksiazyk J, Lagström H, Sanchez Luna M, Migacheva N, Mosselmans JM, Picaud JC, Possner M, Singhal A, Wabitsch M. Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula. Nutrients. 2018 Aug 24;10(9). pii: E1161. doi: 10.3390/nu10091161.

von Berg A, Filipiak-Pittroff B, Krämer U, et al; GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol. 2008;121:1442-1447.

von Berg A, Koletzko S, Filipiak-Pittroff B, et al; German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study. J Allergy Clin Immunol. 2007;119:718-725.

von Berg A, Koletzko S, Grübl A, et al; for the German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow’s milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial. J Allergy Clin Immunol. 2003;111:533–540.

von Berg A, Krämer U, Link E, et al; GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course—the GINIplus study up to the age of 6 years. Clin Exp Allergy. 2010;40:627-636.

von Berg A1, Filipiak-Pittroff B1, Schulz H2,3, Hoffmann U2,4, Link E5, Sußmann M2, Schnappinger M2, Brüske I2, Standl M2, Krämer U5, Hoffmann B5,6, Heinrich J2,3, Bauer CP4,7, Koletzko S8, Berdel D1; GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas--the GINI Study. Allergy. 2016 Feb;71(2):210-9. doi: 10.1111/all.12790. Epub 2015 Nov 23.

Walker WA. Bacterial Colonization of the Newborn Gut, Immune Development, and Prevention of Disease. Nestle Nutr Inst Workshop Ser. 2017;88:23-33. doi: 10.1159/000455210. Epub 2017 Mar 27.

Walker WA. Summary of Evolution of Human Microbiota. Nestle Nutr Inst Workshop Ser. 2017;88:55-56. doi: 10.1159/000455214. Epub 2017 Mar 27.

Willems R, Duchateau J, Magrez P, Denis R, Casimir G. Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Ann Allergy. 1993;71:147–150.